You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 18, November 12, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (26)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Pain
 •End-of-life Care/ Palliative Medicine
 •Alert me on articles by topic

CLINICIAN'S CORNER
Cancer Pain

Eduardo Bruera, MD; Hak Nam Kim, MD

JAMA. 2003;290:2476-2479.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Approximately 1 in 3 individuals in the developed world will be diagnosed with cancer and half of those patients will die of progressive disease.1 More than 80% of patients with cancer develop pain before death.2 Pain is consistently one of the most feared consequences of cancer for both patients and families. Major improvements in the management of cancer pain in recent years include better assessment of pain, recognition and treatment of opioid-induced neurotoxicity, and the emerging use of opioid rotation and of methadone.


Assessment

In approximately two thirds of patients with cancer, pain is directly related to the presence of primary or metastatic disease3; another third of patients with cancer develop pain syndromes because of treatment, including sequelae of surgery, radiation, or chemotherapy, and other related causes such as osteoporosis, immobility, and infections.3 An understanding of the mechanism of the pain . . . [Full Text of this Article]

Management

Pharmacological Management

Adjuvant Drugs

Nonpharmacological Treatment

Conclusion

Author Affiliation: Department of Palliative Care and Rehabilitation Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Tex.


RELATED LETTERS

Management of Cancer Pain
Allen W. Burton, Arun Rajagopal, Charles S. Cleeland, Samuel J. Hassenbusch, III, and Daniel B. Carr
JAMA. 2004;291(9):1067-1068.
EXTRACT | FULL TEXT  

Management of Cancer Pain
Joshua M. Rosenow
JAMA. 2004;291(9):1068.
EXTRACT | FULL TEXT  

Management of Cancer Pain
Chris Flores
JAMA. 2004;291(9):1068.
EXTRACT | FULL TEXT  

Management of Cancer Pain—Reply
Eduardo Bruera
JAMA. 2004;291(9):1068-1069.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Translational medicine: cancer pain mechanisms and management
Delaney et al.
Br J Anaesth 2008;101:87-94.
ABSTRACT | FULL TEXT  

The Devil's Choice: Re-Thinking Law, Ethics, and Symptom Relief in Palliative Care
Magnusson
J Law Med Ethics 2006;34:559-569.
 

Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.
Furlan et al.
CMAJ 2006;174:1589-1594.
ABSTRACT | FULL TEXT  

Pain: Impediments and Suggestions for Solutions
Dahl
J Natl Cancer Inst Monogr 2004;2004:124-126.
ABSTRACT | FULL TEXT  

Management of Cancer Pain
Rosenow
JAMA 2004;291:1068-1068.
FULL TEXT  

Management of Cancer Pain
Burton et al.
JAMA 2004;291:1067-1068.
FULL TEXT  

Management of Cancer Pain
Flores
JAMA 2004;291:1068-1068.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.